← FDA Drug Approvals (Drugs@FDA)
FINASTERIDE AND TADALAFIL
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NOVITIUM PHARMA · Approved 2025-03-19
Drug application
- FDA Application #
ANDA218499- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- FINASTERIDE AND TADALAFIL
- Generic name
- Finasteride
- Active ingredients
- FINASTERIDE; TADALAFIL
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- NOVITIUM PHARMA
- First approval
- 2025-03-19
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown